Results 121 to 130 of about 2,851 (167)

Case report: Epidermolysis bullosa acquisita following dipeptidyl peptidase-4 inhibitor therapy and complicated by immune thrombocytopenic purpura. [PDF]

Front Immunol
Kawamoto H, Sasaki N, Ueda Y, Ishii N, Sawada Y.   +4 more
europepmc   +1 more source

Recalcitrant epidermolysis bullosa acquisita treated with upadacitinib as a bridge to rituximab. [PDF]

JAAD Case Rep
Rasul T, Concilla A, Militello M, Torres P, Stepien A.   +4 more
europepmc   +1 more source

The Retinoid Tamibarotene Aggravates Skin Inflammation in a Model of Bullous Pemphigoid-like Epidermolysis Bullosa Acquisita. [PDF]

Cells
Thieme M, Schilf P, Murthy S, Gonther S, Hammers CM, Heine G, Sadik CD.   +6 more
europepmc   +1 more source

Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita. [PDF]

Front Med (Lausanne), 2021
Zillikens H, Kasprick A, Osterloh C, Gross N, Radziewitz M, Hass C, Hartmann V, Behnen-Härer M, Ernst N, Boch K, Vidarsson G, Visser R, Laskay T, Yu X, Petersen F, Ludwig RJ, Bieber K.   +16 more
europepmc   +1 more source

Epidermolysis Bullosa Acquisita

Annals of Dermatology, 1989
Chang Woo Lee, Hong Yoon Yang, Moon Hyang Park   +2 more
openaire   +1 more source

Evaluation and Comparison of Clinical and iLaboratory Characteristics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa Acquisita.

JAMA Dermatol, 2021
Becker M, Schumacher N, Schmidt E, Zillikens D, Sadik CD.   +4 more
europepmc   +1 more source

Epidermolysis Bullosa Acquisita: A Case Report. [PDF]

Am J Case Rep, 2020
Kumetz EA, Meyerle JH, Rivard SC.
europepmc   +1 more source

Epidermolysis bullosa acquisita: diagnostic difficulties

Przegląd Dermatologiczny
Izabela Staniszewska, Julia Lanckorońska, Agnieszka Kalińska-Bienias   +2 more
doaj   +1 more source

Unusual variants of subepidermal autoimmune bullous diseases [PDF]

, 2011
Buijsrogge, Jacqueline Johanna Angela
core   +4 more sources

Epidermolysis bullosa acquisita as an adverse effect from rituximab therapy: A case report. [PDF]

Medicine (Baltimore), 2020
Wu X, Lv Z, Li W, Meng Z, Wan SP.
europepmc   +1 more source